Cyclooxygenase-2 (COX-2) and nitric oxide synthase-2 (NOS-2), which contribute to immune suppression within TME, represent other markers whose tumor expression can be predictive of the level of immune response and/or outcome [56,57]. This evidence concerns the gene PTGS2 and neoplasm.